%PDF-1.5
%
1 0 obj
<>/OCGs[7 0 R]>>/Pages 2 0 R/Type/Catalog>>
endobj
42 0 obj
<>stream
2021-04-25T05:14:30-07:00
2006-09-29T09:19:32+08:00
2021-04-25T05:14:30-07:00
uuid:5bd4c9e8-c0bb-4df7-b9ed-1cf6846b7ba3
uuid:92c40271-1dd2-11b2-0a00-aa00f824efff
application/pdf
endstream
endobj
2 0 obj
<>
endobj
37 0 obj
<>/Font<>/T1_1<>/T1_2 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
32 0 obj
<>/Font<>/T1_1<>/T1_2<>/T1_3<>/T1_4 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
27 0 obj
<>/Font<>/T1_1<>/T1_2 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
22 0 obj
<>/Font<>/T1_1<>/T1_2<>/T1_3<>/T1_4<>/T1_5 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
17 0 obj
<>/Font<>/T1_1<>/T1_2<>/T1_3<>/T1_4<>/T1_5 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
12 0 obj
<>/Font<>/T1_1<>/T1_2<>/T1_3 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
5 0 obj
<>/Font<>/T1_1<>/T1_2 46 0 R>>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/Type/Page>>
endobj
43 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
59 0 obj
[65 0 R 66 0 R 67 0 R 68 0 R 69 0 R]
endobj
60 0 obj
<>stream
q
540.0594177 0 0 68.6011963 35.9702911 675.3988037 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 85.56995 558.99982 Tm
(1988;48:4827-4833. )Tj
/T1_1 1 Tf
-5.55699 0 Td
(Cancer Res\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 30 598.99994 Tm
(Tumor Cell Lines)Tj
T*
(Growth and Drug Sensitivity in Culture Using Human and Other )Tj
T*
(Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell)Tj
ET
30 504 552 35 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 511.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 503.99994 Tm
(\240 )Tj
/T1_0 1 Tf
23.17895 1 Td
( )Tj
0 0 1 rg
-23.17895 0 Td
(http://cancerres.aacrjournals.org/content/48/17/4827)Tj
0 g
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 483.99997 Tm
(\240 )Tj
0 1 TD
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 463.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 443.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
30 329 552 115 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 411.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 295.4996 424 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44996 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 120.94202 378.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 381.99994 Tm
(\240 )Tj
13.46496 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
(pubs@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 356.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 328.99988 Tm
(\240 )Tj
0 1 TD
(Rightslink site. )Tj
0 1.00001 TD
(Click on "Request Permissions" which will take you to the Copyright Clea\
rance Center's \(CCC\))Tj
23.17895 1 Td
(.)Tj
0 0 1 rg
-23.17895 0 Td
(http://cancerres.aacrjournals.org/content/48/17/4827)Tj
0 g
0 1 TD
(To request permission to re-use all or part of this article, use this li\
nk)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 256.40434 11 Tm
(on April 25, 2021. \251 1988 American Association for Cancer Research. )Tj
0 0 1 rg
-12.11496 0 Td
(cancerres.aacrjournals.org )Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
endstream
endobj
64 0 obj
<>/Filter/FlateDecode/Height 196/Length 86651/Name/X/Subtype/Image/Type/XObject/Width 1543>>stream
HMUI~
͇13ZpcBOǂ7nԅ$BMQ!a=nc&&gC@ $>w=3o1vUN^\q a ȰS @Dd) m"2 6v
h; MD &"N ma ȰS @Dd) m"2 6v
h; MD &"N ma ȰS @Dd) m"2 6v
h; MD &"N 9ߤATEFQ! °(2WZh Nk;s*< >C`mDQEǶhV䝸Ͳ,Iٖz+""^JWF{kի[H\꺑tJ?UaQW=.JNPu3?E34{Y@.0vjnmW:>u
8>Ƭ5GX9_@+1\S;|fAa7%'a6WGyYŐ*\
ͽ[~U}]T! ZeY$߰e:y߭qkNtDQYoQqjTN4砎t`wZ~QkXVUT&N\PH/%XeJrպ
UA;4,eTUe 2tk
6&bijWREAn>لaQzjR,>w;fo[L,H;*5
fiecҶ#ԺFtfϺa{%a5bݡ*S{ʚmVOdmKr9 b߭?zXe`ii۶mѪ_D}i8_Ea^UYVÇ/]tׯ߿aaAWv{ٻw7sNtLXsA݃{\=J;ۋfI&7sɱ8YqnK#Vⲑ0Y>Il>MK_O-OW.r>TGi{l&拯ouэs_Vrf<;IfΎI[Fj~1{clE Ay9Vjh_>ְ~v*ֆ\ >?OݑnKTdCU?c^pX]goߎ9RH:RUWYi{M}q4fs/?~nnٓ'd;:99966tkG?Mҙǎҹ!C7Ĺ_F{"b9^*W<<lٺz_zq+⪒